California Institute of Technology
17
3
4
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.9%
1 terminated/withdrawn out of 17 trials
87.5%
+1.0% vs industry average
6%
1 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Appetitive Conditioning in Anorexia Nervosa
Role: collaborator
Tissue Destruction and Healing in Celiac Disease
Role: collaborator
Neuronal Mechanisms of Human Episodic Memory
Role: collaborator
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
Role: collaborator
Quantifying New Heart Muscle Cells
Role: collaborator
Neural Computations of Goal-directed Decision-making
Role: collaborator
Can Computational Measures of Task Performance Predict Psychiatric Symptoms and Changes in Symptom Severity Across Time
Role: lead
Cognitive Function Evaluation and Rehabilitation by a Digital Game: MentalPlus®
Role: collaborator
Brain Development Research Program
Role: collaborator
Targeting Diet-Microbiome Interactions in the Pathogenesis of Parkinson's Disease
Role: collaborator
Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
Role: collaborator
Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks
Role: collaborator
Establishing a Non-invasive Method to Measure Your Heart's Performance
Role: collaborator
Restoring Arm and Hand Function With Non-invasive Spinal Stimulation
Role: collaborator
Transcutaneous Electrical Spinal Cord Stimulation for Lower Limbs
Role: collaborator
Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma
Role: collaborator
The Neural Correlates of Food Choice Decision-making in Obesity and Weight Loss
Role: collaborator
All 17 trials loaded